Summary & Overview
HCPCS J3535: Drug Administered via Metered Dose Inhaler
HCPCS Level II code J3535 denotes a drug supplied for administration via a metered dose inhaler. Nationally, inhaled medications billed under this code are important for management of respiratory conditions such as asthma and COPD and for consistent claims processing across outpatient and ambulatory care sites. Clear coding of inhaler-delivered drugs supports accurate reimbursement, utilization tracking, and patient access to inhaled therapies.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a compact briefing on clinical context and typical settings for use, plus an overview of what to expect in payer coverage policies. The publication outlines benchmarks and policy-relevant considerations related to billing inhaler-delivered medications, plus coding guidance and common modifiers where applicable.
The content is intended for clinicians, billing professionals, and policy analysts seeking concise guidance on the purpose and application of HCPCS Level II code J3535, including where the service is commonly provided and the payer landscape for national billing practices.
Billing Code Overview
HCPCS Level II code J3535 represents a drug administered through a metered dose inhaler. This code is used to report the supply or administration of a medication packaged for delivery via a metered dose inhaler.
Service Type: Medication administration via metered dose inhaler
Typical Site of Service: Outpatient clinic, physician office, hospital outpatient department, and other ambulatory settings where inhaled medications are dispensed or administered
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 58-year-old patient with moderate persistent asthma presents to an outpatient pulmonary clinic for acute worsening of cough and wheeze despite baseline inhaled controller therapy. The clinician determines that administration of a short-acting bronchodilator via metered dose inhaler is appropriate during the visit for symptom relief and assessment of response. Nursing documents vital signs, administers medication using a J3535 metered dose inhaler (MDI) preparation per facility protocol, observes the patient for adverse reaction for 15–30 minutes, and records medication lot number and dose in the medical record. The care team may provide teaching on MDI technique and arrange follow-up with the prescribing clinician or refill authorization if indicated.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service | Use when an E/M visit on the same day is significant and distinct from J3535 administration (e.g., new problem evaluation). |
59 |